Literature DB >> 20077881

[Phyllodes tumor: institutional experience].

Carlos Aranda Flores1, Emilio José Olaya Guzmán, Alinne Colin Valenzuela, Pedro Silvestre Miguel Pérez.   

Abstract

BACKGROUND: Phyllodes tumor represents one of the fibroepithelial breast neoplasms that accounts for 0.3% to 1% of the breast tumors.
OBJECTIVE: To describe a case series of patients with phyllodes tumor diagnosis.
MATERIAL AND METHODS: We retrospectively reviewed the medical records of patients that had confirmed histological phyllodes tumor collected over a period of ten years.
RESULTS: The incidence was 0.8%, 12.5% of cases corresponded to malignant phyllodes. The average age was 35 years (range 14-50 years); the most frequent site of localization was the superior and external quadrant of the breast; the average tumoral size by image studies (ultrasound or mastography) and by direct measurement was 61 mm (13-150 mm) and 77 mm (30-300 mm), respectively. One case coexisted with pregnancy.
CONCLUSIONS: It is a rare neoplasm, andthe clinician must be aware of its timely diagnosis and treatment, if not some cases will develop breast deformity and some others will be borderline or malignant.

Entities:  

Mesh:

Year:  2009        PMID: 20077881

Source DB:  PubMed          Journal:  Ginecol Obstet Mex        ISSN: 0300-9041


  3 in total

1.  Aggressive palliative surgery in metastatic phyllodes tumor: impact on quality of life.

Authors:  A S Kapali; M Singh; Svs Deo; N K Shukla; Dillip K Muduly
Journal:  Indian J Palliat Care       Date:  2010-05

2.  Phyllodes Tumor of the Breast: 307 Treated Cases, the Largest Mexican Experience at a Single Breast Disease Institution.

Authors:  Eva Ruvalcaba-Limón; Josefina Jiménez-López; Verónica Bautista-Piña; Julio Ramírez-Bollas; Flavia Morales-Vásquez; Carlos Domínguez-Reyes; Antonio Maffuz-Aziz; Sergio Rodríguez-Cuevas
Journal:  Iran J Pathol       Date:  2016

3.  Huge Fungating Benign Phyllodes Tumor of Breast.

Authors:  Altaf Hussain Rathore
Journal:  Pak J Med Sci       Date:  2018 May-Jun       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.